Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Aarhus Universitet Forside
Hjælp og OSS
English
Dansk
Forside
Profiler
Forskningsenheder
Projekter
Publikation
Priser
Aktiviteter
Kurser
Presse/medier
Søg efter ekspertise, navn eller tilknytning
Kim Munk
Forsker
,
Institut for Klinisk Medicin - Hjertesygdomme
Fastnet
+4578452254
E-mail
kim.munk
clin.au
dk
Palle Juul-Jensens Boulevard 69
8200
Aarhus N
Danmark
2003
2024
Publikationer pr. år
Vis
Fingeraftryk
Netværk
Publikation
(39)
Aktiviteter
(4)
Lignende profiler
(6)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Kim Munk er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Medicine and Dentistry
Acute Heart Infarction
57%
Advanced Glycation End-Product
14%
Angina pectoris
14%
Angioplasty
14%
Aortic Arch
17%
Aortic Valve
22%
Blood Pressure
19%
Cardiovascular Risk
14%
Cardiovascular System
12%
Coarctation of the Aorta
28%
Cohort Analysis
14%
Collateral Circulation
14%
Conditioning
100%
Coronary Artery Fistula
14%
Cost-Effectiveness Analysis
14%
Differential Diagnosis
14%
Drug Therapy
19%
Echocardiography
14%
End-Systolic Volume
13%
Gated SPECT
14%
Glucose-6-Phosphate Dehydrogenase Deficiency
14%
Heart Failure
29%
Heart Function
14%
Heart Graft
14%
Heart Left Ventricle Ejection Fraction
13%
Heart Ventricle Septum Rupture
14%
Hemodynamic
14%
Hypothyroidism
14%
Infarction
16%
Ischemic Postconditioning
14%
Liver Cirrhosis
14%
Malignant Neoplasm
14%
Obstruction
14%
Patient with Tetralogy of Fallot
15%
Percutaneous Intervention
16%
Primary Percutaneous Coronary Intervention
68%
Pulmonary Valve
14%
Pulmonary Valve Replacement
23%
Pulse Pressure
14%
Randomized Controlled Trial
29%
Receptor
14%
Renin Angiotensin Aldosterone System
14%
Severe Renal Impairment
14%
Shunting
17%
ST Segment Elevation Myocardial Infarction
88%
Subgroup Analysis
28%
Surgery
19%
Takotsubo Cardiomyopathy
14%
Tetralogy of Fallot
14%
Transesophageal Echocardiography
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
42%
Advanced Glycation End Product
14%
Aldosterone
14%
All Cause Mortality
7%
Angiotensin
14%
Aortic Coarctation
14%
Cardiovascular Risk
17%
Coronary Artery Atherosclerosis
14%
Coronary Artery Disease
8%
Event Free Survival
7%
Heart Arrest
14%
Heart Infarction
33%
Heart Ventricle Septum Rupture
14%
Infarction
26%
Ischemia
10%
Limb Ischemia
7%
Liver Cirrhosis
14%
Methylphenidate
14%
Osteoprotegerin
14%
Randomized Controlled Trial
28%
Receptor
14%
Renin
14%
Risk Evaluation
7%
Severe Renal Impairment
14%
ST Segment Elevation Myocardial Infarction
77%
Statin (Protein)
7%
Takotsubo Cardiomyopathy
14%
Nursing and Health Professions
Acute Heart Infarction
28%
Angioplasty
14%
Blood Flow
14%
Blood Pressure Cuff
9%
Cardiovascular Risk
14%
Clinical Outcome
7%
Coronary Artery Atherosclerosis
14%
Coronary Artery Disease
8%
Cost Effectiveness Analysis
14%
Differential Diagnosis
14%
Drug Therapy
14%
Gated Single Photon Emission Computed Tomography
14%
Glucose Level
7%
Healthcare System
16%
Ischemia
9%
Lipid Level
7%
Liver Cirrhosis
14%
Percutaneous Coronary Intervention
66%
ST Segment Elevation Myocardial Infarction
55%
Statin (Protein)
7%
Takotsubo Cardiomyopathy
14%
